Author:
Chen Grace,Højer Astrid-Maria,Areberg Johan,Nomikos George
Funder
Takeda Development Center Americas, Inc.
H. Lundbeck A/S
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference53 articles.
1. Lundbeck. Trintellix [package insert]. Deerfield (IL): Lundbeck; 2016.
2. Koenig AM, Thase ME. First-line pharmacotherapies for depression: what is the best choice? Pol Arch Med Wewn. 2009;119(7–8):478–86.
3. Lomas J, Llewellyn A, Soares M, Simmonds M, Wright K, Eastwood A, et al. The clinical and cost effectiveness of vortioxetine for the treatment of a major depressive episode in patients with failed prior antidepressant therapy: a critique of the evidence. Pharmacoeconomics. 2016;34(9):901–12.
https://doi.org/10.1007/s40273-016-0417-9
.
4. Connolly KR, Thase ME. Vortioxetine: a new treatment for major depressive disorder. Expert Opin Pharmacother. 2016;17(3):421–31.
https://doi.org/10.1517/14656566.2016.1133588
.
5. Brignone M, Diamand F, Painchault C, Takyar S. Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder. Curr Med Res Opin. 2016;32(2):351–66.
https://doi.org/10.1185/03007995.2015.1128404
.
Cited by
107 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献